JOHNSON & JOHNSON Accounts Payable 2008-2026 | JNJ
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is JOHNSON & JOHNSON's current accounts payable?
JOHNSON & JOHNSON (JNJ) annual accounts payable for 2025 was $11.99B, a 16.29% increase from 2024. JOHNSON & JOHNSON accounts payable for the quarter ending March 29, 2026 was $10.46B.
What was JOHNSON & JOHNSON's accounts payable in 2024?
JOHNSON & JOHNSON annual accounts payable for 2024 was $10.31B, a 7.05% increase from 2023.
What was JOHNSON & JOHNSON's accounts payable in 2023?
JOHNSON & JOHNSON annual accounts payable for 2023 was $9.63B, a 12.87% decline from 2022.
What is JOHNSON & JOHNSON's 4-year accounts payable CAGR?
JOHNSON & JOHNSON accounts payable grew at a compound annual growth rate (CAGR) of 5.98% from FY2021 to FY2025, going from $9.51B to $11.99B over 4 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+7.0%
FY2019
$8.54B
→
FY2025
$11.99B
081011121314161718192122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $11.99B | +16.3% | 10-K |
| FY2024 | $10.31B | +7.0% | 10-K |
| FY2023 | $9.63B | -12.9% | 10-K |
| FY2022 | $11.05B | +16.3% | 10-K |
| FY2021 | $9.51B | +11.2% | 10-K |
| FY2019 | $8.54B | +13.4% | 10-K |
| FY2018 | $7.54B | +3.1% | 10-K |
| FY2017 | $7.31B | +9.6% | 10-K |
| FY2016 | $6.67B | -12.6% | 10-K |
| FY2014 | $7.63B | +21.8% | 10-K |
| FY2013 | $6.27B | +7.5% | 10-K |
| FY2012 | $5.83B | +3.7% | 10-K |
| FY2011 | $5.62B | +1.5% | 10-K |
| FY2010 | $5.54B | -26.1% | 10-K |
| FY2008 | $7.50B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →